The cancer hypothesis of pulmonary arterial hypertension: the next ten years

The Hallmarks of Severe Pulmonary Arterial Hypertension: The Cancer Hypothesis - Ten years later

(2020) Carlyne D Cool et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Discovery of Distinct Immune Phenotypes Using Machine Learning in Pulmonary Arterial Hypertension

(2019) Andrew J Sweatt et al.   CIRCULATION RESEARCH

A Pro - Con debate: Current Controversies in PAH Pathogenesis at the American Thoracic Society International Meeting in 2017

(2018) Wolfgang Michael Kuebler et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Emerging therapeutics in pulmonary hypertension

(2018) Matthew K. Hensley et al.   AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY

Repurposing Medications for Treatment of Pulmonary Arterial Hypertension: What's Old Is New Again

(2018) Kurt W. Prins et al.   Journal of the American Heart Association

Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients

(2017) Evangelos D. Michelakis et al.   Science Translational Medicine

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL